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Journal of Nanomedicine Research

Mechanisms of Nanosecond Pulsed Electric Field
(NsPEF)-Induced Cell Death in Cells and Tumors
Abstract
The evolution of pulse power technology from high power physics to biology and
medicine places nanosecond pulsed electric fields (nsPEFs) in positions for in
vitro and in vivo applications as non-ligand agonists that not only bypass plasma
membrane receptors for induction of intracellular signaling pathways, but also bypass
intracellular oncogenic impasses to induce cell death by regulated mechanisms.
Based on work reviewed here, a likely scenario for cell and tumor demise includes
nsPEF-induced permeabilization of the plasma membrane, Ca2+ influx, dissipation
of the mitochondrial membrane potential, which is likely due to events beyond
permeabilization of the inner mitochondrial membrane, cytochrome c release
and activation of caspase-dependent and -independent cell death mechanisms. In
vivo, nsPEF-treated orthotopic rat N1-S1 hepatocellular carcinoma tumors exhibit
caspase-9 and caspase-3 positive and –negative tumor cells, indicating intrinsic
apoptotic and non-apoptotic cell death. Interestingly, after N1-S1 tumor ablation
and clearance, rats are resistant to challenge injections of the same N1-S1 tumor
cells, indicating a protective, vaccine-like effect that appears to be due to innate and/
or adaptive immune responses that are under further investigation. This provides
additional impetus to further develop nsPEF ablation as a cancer therapy.

Mini Review
Volume 2 Issue 1 - 2015

Stephen Beebe J*

Frank Ready Research Center for Bioelectrics, USA
*Corresponding author: Stephen Beebe J, Frank
Ready Research Center for Bioelectrics, 4211
Monarch Way, IRP, II Room 341, 23510, Virginia,
USA, Tel: (757) 683-2405; Fax: (757) 451-1010;
Email:

Received: December 10, 2014| Published: January 02,
2015

Keywords

Electric fields; Calcium; Mitochondria membrane potential; Mitochondria permeability
transition pore; Cytochrome c; Caspases, Apoptosis; Non-apoptotic cell death;
Hepatocellular carcinoma; Vaccine-like effect

Abbreviations

NsPEFs: Nanosecond Pulsed Electric Fields; mPTP:
Mitochondria Permeability Transition Pore; VDAC: Voltage
Dependent Anion Channel; ANT: Adenine Nucleotide Transporter;
DISC: Death-Induced Signaling Complex; IRE: Irreversible
Electroporation; HCC: Hepatocellular Carcinoma

Introduction

A major problem that cancer therapeutics faces today
is coping with a diversity of cancer diseases. Hanahan and
Weinberg [1,2] reasoned that since all mammalian cells express
the same molecular mechanisms for proliferation, differentiation
and death, cancers should share a limited number of systems
that govern their behavior. This is insightful because cancers
represent an array of diseases. To develop cancer research into
a more logical science and to provide a focused characterization
of cancer, Hanahan and Weinberg [1] defined six major hallmarks
of cancer that control cell homeostasis and proliferation. These
include self-sufficiency in growth signals, insensitivity to growthinhibitory (antigrowth) signals, evasion of apoptosis, limitless
replicative potential, sustained angiogenesis, and tissue invasion
and metastasis. Progress made in the last decade has added
two emerging hallmarks including reprogramming of energy
metabolism and evading immune destruction [2]. More recently
Vogelstein et al. [3] defined a cancer genome landscape, finding
that cancers are “pathway diseases” with two to eight “driver
gene” mutations from a class of 12 signaling pathways that
Submit Manuscript | http://medcraveonline.com

regulate three core cellular processes: cell fate, cell survival
and genome maintenance. With an evolving understanding of
molecular mechanisms of cancer, treatment strategies using
mutation-specific small molecule drugs or monoclonal antibodies
have been developed to specifically target some cancers in the
perspective of defined cancer hallmarks. One example is the
treatment of B-RAF oncoprotein in melanoma, which provides
sufficiency of growth signals [4]. However, tumors treated with
B-RAF inhibitors nearly always develop resistance after about
six to nine months of treatment, and the tumors return or begin
growing again. Thus, new treatment modalities to treat cancer
are needed. When these new modalities are introduced it should
be of interest to determine which of the hallmarks of cancer are
targeted. Furthermore, increasing evidence indicates that it is
important to know mechanisms of cell death.
During developmental and homeostatic cell death,
apoptosis is anti-inflammatory and immunologically silent.
However, a number of recent studies indicate that caspasedependent processes are important for immunogenicity [5].
In chemotherapy-induced cell death, some (anthracyclins),
but not all (mitomycin C) caspase-inducing stimuli initiates’
immunogenic cell death [6], thus immunogenicity depends
on factors other than caspase activation. Apoptosis has been
shown to induce maturation of dendritic cells leading to T-cell
activation and immunity [7] and apoptotic cells not only undergo
degradation, but also deliver processed antigen to dendritic cells
for cross-presentation [8]. Immunogenic cell death has obvious
advantages for cancer treatment.
J Nanomed Res 2015, 2(1): 00016
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There are advantages and disadvantages to investigating
cell death mechanisms both in vitro and in vivo and in a word
they are reciprocal. In vitro experiments with cells allow more
flexibility in experimental designs, but they exclude systems of
the entire living organism. In vivo studies include systems of
the entire living organism, but they allow much less flexibility
in experimental designs. Thus, approaches should include both
experimental strategies and determine whether or not in vitro
results translate into in vivo realities.

Over the last decade, a novel cancer treatment strategy makes
use of pulse power technology by applying nanosecond pulsed
electric fields (nsPEFs) to cancer cells and tumors. Pulse power
compresses electric energy and releases it in sub micro second
bursts that achieve high power and low energy. When a stored
joule of energy is released all at once in one second, the peak
power delivered is only 1 watt (101). When it is released in a
microsecond, the power is one megawatt (106); when it is release
in one nanosecond the peak power is one giga watt (109). NsPEFs
cause cell membrane supra-electroporation resulting in high
density “nanopores” (nm diameter) in all cellular membranes
[9,10]. Vernier et al. [11] demonstrated that nanopores facilitated
voltage-driven phosphatidyl serine translocation in lipid bilayers
and Pakhomov et al. [12] identified lipid nanopores in cell
membranes that formed stable, ion channel-like conduction
pathways. This is a unique transition of a technology used in
high power physics to applications in biology and medicine. In
this brief discussion, an overview of in vitro and in vivo results
using nsPEFs is presented as an alternative therapy for cancer
treatment.

Some Lessons Learned from In Vitro Experiments

A series of studies highlighted here provided insight into
effects of nsPEFs on plasma membranes, mitochondria and cell
death mechanisms. In one series of studies we looked at effects
of nsPEFs on plasma membranes as Ca2+ influx using Fluo-4
and on intracellular organelles as changes in the mitochondria
membrane potential (ΔΨm) with TMRE. We used 4 different
nsPEF waveforms that differed in their rise-fall times and
bipolar components at the end of the pulse (bipolar tails) [13].
These studies are based on the hypothesis that high frequency
components are important for intracellular effects of nsPEFs
[14]. In another series, we looked at activation of caspase-3, -9
and -8 and cell death in Jurkat cell mutants that were deficient in
key protein in extrinsic (FADD, caspase-8) and intrinsic (APAF-1)
apoptosis pathways [15]. Thus, the following results are a review
of mostly recent work from the Beebe laboratory [13-22].
NsPEF induce plasma membrane poration at lower electric
fields than that required for loss of the mitochondria membrane
potential (ΔΨm), indicating that nsPEFs affect plasma membranes
more readily that intracellular membranes or organelles. High
frequency components of nsPEFs (frequency in Hz=1/time in
sec) are most effective to dissipate the mitochondria membrane
potential (ΔΨm), but are less important for plasma membrane
permeabilization using Ca2+ influx as a marker. Thus, the pulse
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waveform appears to selectively affect ΔΨm and possibly other
intracellular components. Cell death is closely correlated with
loss of ΔΨm; high intracellular Ca2+ is necessary, but not sufficient
for cell death. Thus, nsPEF-induced cell death requires both
influx of extracellular Ca2+ and dissipation of ΔΨm [20,21]. This
is consistent with a “two hit” hypothesis for cell death [23,24]. At
electric fields sufficient to induce cell death in 40-60% of cells,
dissipation of ΔΨm is calcium-dependent. At electric fields that
induce cell death in 90% of cells, dissipation of ΔΨm is partially
Ca2+-independent. This suggests two different thresholds for
nsPEF effects on ΔΨm, the higher threshold, but not the lower
one, is most likely permeabilization of the inner mitochondrial
membrane. Plasma membrane permeabilization is not Ca2+
dependent, suggesting effects on ΔΨm at the lower threshold are
due to events other than permeabilization. Since essentially all
Ca2+-mediated effects depend on a protein(s), nsPEFs-induced
dissipation of ΔΨm may include effects on a protein or protein
complex [20,21]. Showing a direct electric field effect on a protein,
nsPEFs inactivated the catalytic subunit of the cAMP-dependent
protein kinase (PKA) [22]. The most likely protein complex for a
nsPEF effect on ΔΨm is the mitochondria permeability transition
pore (mPTP) complex. However, inhibitors of components of the
mPTP complex or associated proteins, including cyclophilin D,
voltage dependent anion channel (VDAC) and adenine nucleotide
transporter (ANT), had no effect on nsPEF-induced loss of ΔΨm
[22]. Furthermore, over expression of Bcl-xl, which binds to VDAC
and attenuated heat stress- and genotoxic-induced apoptosis in
the same Jurkat clone [25,26], had no effect on nsPEF-induced
dissipation of ΔΨm or cell death [Beebe, unpublished].
Using Jurkat clones that were deficient in FADD and
caspase-8, abolishing formation of the death-induced signaling
complex (DISC) and other FADD complexes, did not prevent
nsPEF-induced cell death, indicating that FADD and the DISC
was not necessary for nsPEF-induced cell death [15]. However,
cell survival in U937 cells and Jurkat cells following 10 ns pulse
exposures depends on extrinsic apoptotic regulators cFLIP and
FAS ligand, respectively [27]. Using a Jurkat clone that was APAF1deficient demonstrated that nsPEF-induced cell death (ten 60 ns
pulses) is caspase-dependent at intermediate electric fields (2040 kV/cm) and caspase-independent at high electric fields (≥ 50
kV/cm), underscoring that in response to nsPEFs, apoptosis is not
the only executed form of cell death [15]. Cells can be driven into
cell death subroutines that include necrotic features [28,29]. Cal
pains, which are activated by nsPEFs [20,30], have been shown to
be involved in calpain-dependent necrotic and/or apoptosis-like
programmed cell death [31]. These data indicate that oncogenic
mechanisms that block cell death by over expressing of Bcl-xl,
blocking the DISC or FADD complexes or preventing caspase
activation can be bypassed by nsPEF ablation.

Cancer Therapy with Electric Fields

Approaches using electric fields as cancer therapy
include electrochemotherapy delivering poorly permeable
chemotherapeutic agents by electroporation [32,33] or
electroporation to deliver DNA [34]. These topics have been
recently reviewed [35,36]. Another therapy based on uses
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of electric fields is irreversible electroporation (IRE), which
increases electric fields to produce cell necrosis through
irreversible plasma cell membrane defects [37].

Treatment of Cancer using Pulsed Power with NsPEFs

Another extension of conventional electroporation takes
greater advantage of pulsed power technology with nsPEFs,
which continues to be explored for tumor ablation. Within the
last decade, applications of ultra-high pulse power have been
extended to biology, medicine and cancer therapy [19,38], as
indicated by successful treatment of mouse B16 melanoma
[39,40], a human basal cell carcinoma [41] and mouse ectopic
hepatocellular carcinoma (HCC) [42]. More recently, an
orthotopic rat N1S1 HCC has been successfully treated [43,44].
Efficacy of nsPEFs has been demonstrated for murine basal cell
carcinoma [45] and human pancreatic carcinoma in a murine
xenograft model [46]. It has also shown in the first human trial
that nsPEFs or nano-electro-ablation eliminated 7 of 10 basal
cell carcinomas, while 2 partially regressed. After treatment
two of the 7 exhibited seborrheic keratosis in the absence of
basaloid cells and one treated lesion recurred by week 10 and
histologically had the appearance of a squamous cell carcinoma.
These treatments left no visible scars at the treatment sites [47].

Treatment of Orthotopic Rat N1S1 HCC with nsPEFs

N1-S1 HCC tumors were initiated and treated 7 days later
when tumors were about 55x55 mm. NsPEF treatments were
delivered to tumor tissue using a 5 needle electrode array [44].
Treatments included pulses with 100 ns durations, electric field
strengths of 50 kV/cm and various pulse numbers from 100 to
1000 with repetition rates of 1 Hz. Tumor growth was followed
by ultrasound. Rats were euthanized when heavy tumor burden
was detected or at study end points. Tumors were weighed and
volumes were determined or classified as complete response if no
significant masses were observed; as a partial response if tumors
were small, but still growing slowly; as stable, if tumors were
present but not growing; and no response if tumors grew so large
that euthanasia was required due to tumor burden.

Tumors that were treated with 100, 300 or 500 pulses were
not visible at 2 weeks, but by 6 weeks had begun to grow again.
In a large study, tumors received either sham treatment or 1000
pulses, 100 ns, 50 kV/cm at 1 Hz. Greater than 80% of tumors were
completely eliminated. Two tumors showed partial responses,
one tumor was stable and three others continued to grow albeit
slowly without a response. Sham-treated tumors readily grew,
eventually requiring euthanasia due to tumor burden. Active
caspases-3 and -9 were present in tumors 1, 2, 4 and 6 h after
treatment, but not in sham-treated tumors. Active caspase-8 was
not readily identified at any time points. By 6 h after treatment,
about 50% and 40% of cells showed active caspase-3 and -9,
respectively. Not all cells expressed active caspases indicating
that not all cells die by apoptosis.
In another large study, tumors ablated with 1000 pulses
with 100 ns, 50 kV/cm and at 1Hz were followed by challenge
injections of the same cells 7 weeks after treatment. Twenty
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animals were sham-treated and 23 were treated with nsPEFs.
Within 40 days 21 or 91.3% of rats were tumor free while all
sham-treated rats required euthanasia due to tumor burden. The
21 surviving rats were then challenged with a second injection
identical to the initial one in either the same lobe that carried the
tumor or an adjacent right lobe. All 21 rats with nsPEF-ablated
tumors remained tumor free for as long as 20 weeks, when
the study was terminated. In contrast, 24 age-matched, naïve
control rats (shipping mates of those initially treated) required
euthanasia between 4-5 weeks after injection due to tumor
burden. Thus a vaccine-like, protective affect is evident which
prevents recurrence after complete nsPEF ablation.

Possible Advantages for NsPEF Ablation as a Cancer
Therapy

There may be several advantages for using nsPEF ablation
as a means for cancer therapy as opposed to other physical
methods that rely on overt necrosis for tumor cell death. One
advantage is that nsPEFs target multiple programmed cell death
mechanisms for apoptosis induction and anti-angiogenesis, two
well-known cancer hallmarks, the latter necessary for a third
cancer hallmark, invasion and metastasis [40]. In addition,
the treatment is rapid, targeting multiple death mechanisms
with minimal treatment exposures, which reduces chances
for resistances and recurrences. The electric fields also target
mitochondria-mediated programmed cell death, which can
bypass many cancer-causing mutations. While nsPEFs exhibit
some cell specificity, with high electric fields, a broad specificity
for cell death induction occurs in the tumor mass and the
microenvironment, including rapidly growing tumor cells, slower
growing host cells that collaborate with tumor cells and cancer
stem cells (the latter has not been shown directly). The treatment
causes local infarction of small vessels, depriving tumors of feeder
vessels, which disrupts nutrient and oxygen supplies inducing
local stresses with minimal local and systemic side effects. Finally
there is a possibility that nsPEFs enhance immune surveillance
from cells undergoing apoptosis. There is accumulating evidence
that the presence of apoptotic cells is advantageous for antigen
presentation [6,7,47-50]. Surface exposure of immunogenic
effectors is facilitated during early apoptosis, caspase activation
and endoplasmic reticulum stress. This is followed by the release
of soluble factors that are indispensable for effective immune
response [51].

Conclusion

NsPEFs induce both caspase-dependent (apoptosis) and
caspase-independent cell death in tumor cells and tissues through
pathways that appear to be mediated, at least in part, by intrinsic
mechanisms. It is clear that apoptosis is not the sole form of cell
death executed in response to nsPEFs and that different nsPEF
conditions may induce different mechanisms for cell demise.
Two prominent events that lead to cell death are influx of Ca2+
through permeabilized plasma membranes and dissipation of
the ΔΨm by a mechanism(s) that may include nsPEF-induced
effects on a protein(s). Caspase-dependent (apoptotic) and
caspase-independent cell death may enhance immunogenic cell
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death that can possibly generate inherent resistances to further
development of the treated type of cancer, mimicking a vaccine
effect.
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